Antenatal corticosteroids and newborn respiratory outcomes in twins: A regression discontinuity study
BJOG: An International Journal of Obstetrics & Gynaecology · 2024
DOI: 10.1111/1471-0528.17754 ↗Kurz gefasst
Fachartikel in der Zeitschrift BJOG: An International Journal of Obstetrics & Gynaecology, 2024. Verfasst von Peter M Socha und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada. Hauptthemen laut MEDLINE: Respiratory Distress Syndrome, Newborn, Pregnancy, Twin, Prenatal Care, Adrenal Cortex Hormones. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Fonds de Recherche du Québec - Santé, Canadian Institutes of Health Research.
Abstract (Originalsprache)
Objective
To estimate the effect of antenatal corticosteroids on newborn respiratory morbidity in twins.
Design
Regression discontinuity applied to population‐based birth registry data.
Setting
British Columbia, Canada, 2008–2018. Population Twin pregnancies admitted for birth between 31 +0 and 36 +6 weeks of gestation.
Methods
During our study period, Canadian clinical practice guidelines recommended antenatal corticosteroid administration for imminent preterm birth up to 33 +6 weeks. We used a logistic model to compare the predicted risks of our outcomes among pregnancies admitted for birth immediately before this clinical cut‐point (higher probability of exposure to antenatal corticosteroids) versus immediately after it (lower probability). Main outcome measures Our primary outcome was a composite of newborn respiratory distress or in‐hospital death. Our secondary outcome was a composite of newborn respiratory intervention or in‐hospital death.
Results
Among 2524 pregnancies (5035 liveborn twins), 47% of admissions before 34 +0 weeks of gestation were exposed to antenatal corticosteroids but only 4.2% of admissions after this cut‐point were exposed. The risk of newborn respiratory distress or in‐hospital mortality increased abruptly at 34 +0 weeks, corresponding to a protective effect of treatment (risk ratio [RR] 0.69, 95% CI 0.53–0.90; risk difference [RD] −12 cases per 100 births, 95% CI −20 to −4.1). There was no clear evidence for or against an effect on newborn respiratory intervention or in‐hospital death (RR 0.89, 95% CI 0.70–1.13; RD −4.2 per 100, 95% CI −13 to +4.2).
Conclusions
Our findings provide evidence for the effectiveness of antenatal corticosteroids in preventing adverse newborn respiratory outcomes in twins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montréal, Quebec, Canada.
- Department of Economics, McGill University, Montréal, Quebec, Canada.
- Department of Obstetrics and Gynaecology, University of Toronto, Toronto, Ontario, Canada.
- Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, British Columbia, Canada.
ORCID-Profile: Peter M Socha
Förderung
- CIHR
- Fonds de Recherche du Québec - Santé
- Canadian Institutes of Health Research
Zitieren
APA
Socha, P. M., Harper, S., Strumpf, E., Murphy, K. E., & Hutcheon, J. A. (2024). Antenatal corticosteroids and newborn respiratory outcomes in twins: A regression discontinuity study. BJOG: An International Journal of Obstetrics & Gynaecology. https://doi.org/10.1111/1471-0528.17754
Vancouver
Socha PM, Harper S, Strumpf E, Murphy KE, Hutcheon JA. Antenatal corticosteroids and newborn respiratory outcomes in twins: A regression discontinuity study. BJOG: An International Journal of Obstetrics & Gynaecology. 2024. doi:10.1111/1471-0528.17754
BibTeX
@article{Socha2024,
author = {Socha, Peter M and Harper, Sam and Strumpf, Erin and Murphy, Kellie E and Hutcheon, Jennifer A},
title = {Antenatal corticosteroids and newborn respiratory outcomes in twins: A regression discontinuity study},
journal = {BJOG: An International Journal of Obstetrics & Gynaecology},
year = {2024},
doi = {10.1111/1471-0528.17754}
}
EUVIMED